Regenerative medicine technique brings surgeons one step closer to helping patients
A new study by researchers at Children’s Hospital Los Angeles has shown that tissue-engineered small intestine grown from human cells replicates key aspects of a functioning human intestine. The tissue-engineered small intestine they developed contains important elements of the mucosal lining and support structures, including the ability to absorb sugars, and even tiny or ultra-structural components like cellular connections.
Published online January 8 by the American Journal of Physiology: GI & Liver, the work brings surgeons one step closer to helping human patients using this regenerative medicine technique.
Tissue-engineered small intestine (TESI) grows from stem cells contained in the intestine and offers a promising treatment for short bowel syndrome (SBS), a major cause of intestinal failure, particularly in premature babies and newborns with congenital intestinal anomalies. TESI may one day offer a therapeutic alternative to the current standard treatment, which is intestinal transplantation, and could potentially solve its largest challenges – donor shortage and the need for lifelong immunosuppression.
Tracy C. Grikscheit, MD, a principal investigator in The Saban Research Institute of CHLA and its Developmental Biology and Regenerative Medicine program, is also a pediatric surgeon at Children’s Hospital Los Angeles and an assistant professor of surgery at the Keck School of Medicine of the University of Southern California.
Grikscheit aims to help her most vulnerable young patients, including babies who are born prematurely and develop a devastating disease called necrotizing enterocolitis (NEC), where life-threatening intestinal damage requires removal of large portions of the small intestine. Without enough intestinal length, the babies are dependent on intravenous feeding, which is costly and may cause liver damage. NEC and other contributors to intestinal failure occur in 24.5 out of 100,000 live births, and the incidence of SBS is increasing. Nearly a third of patients die within five years.
CHLA scientists had previously shown that TESI could be generated from human small intestine donor tissue implanted into immunocompromised mice. However, in those initial studies – published in July 2011 in the biomedical journal Tissue Engineering, Part A – only basic components of the intestine were identified. For clinical relevance, it remained necessary to more fully investigate intact components of function such as the ability to form a healthy barrier while still absorbing nutrition or specific mechanisms of electrolyte exchange.
The new study determined that mouse TESI is highly similar to the TESI derived from human cells, and that both contain important building blocks such as the stem and progenitor cells that will continue to regenerate the intestine as a living tissue replacement. And these cells are found within the engineered tissue in specific locations and in close proximity to other specialized cells that are known to be necessary in healthy human intestine for a fully functioning organ.
The Latest on: Regenerative medicine
via Google News
The Latest on: Regenerative medicine
- Stem cell roadmap provides vision, funding for Australia's regenerative medicine sectoron November 12, 2019 at 9:06 pm
MELBOURNE, Australia – Although Australia was one of the first movers in the regenerative medicine space, until now a cohesive plan for investing in regenerative medicine was holding the sector back, ...
- Learn How You Can Treat Your Pain with Regenerative Medicine!on November 12, 2019 at 11:14 am
Join us Monday, December 16, 7PM at the Woodbridge Main Library as Manisha Chahal, MD of Edison-Metuchen Orthopaedic Group discusses Regenerative Medicine to Treat Pain. Dr. Chahal will walk us ...
- Superior Healthcare - Regenerative Medicineon November 12, 2019 at 8:39 am
The future of medicine is regenerative medicine and this morning, we have Dr. Jeremy Wilson here with us from Superior Healthcare to explain what regenerative medicine is.
- Regenerative Medicine Market Advance Research in Medical Sector 2019 to 2025on November 8, 2019 at 4:14 am
Nov 08, 2019 (Market Insight Reports via COMTEX) -- "Global Regenerative Medicine Market Research Report 2019" presents an in-depth assessment of the Global Regenerative Medicine market dynamics, ...
- Regenerative Medicine Market Emerging Trends and Will Generate New Growth Opportunities Statuson November 8, 2019 at 2:16 am
Nov 08, 2019 (WiredRelease via COMTEX) -- The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% ...
- Novel material for regenerative medicine can control cell immune responseon November 6, 2019 at 2:09 am
Researchers have created a material that can manipulate the immune response and be used as a regenerative medicine therapy. Researchers have created a new material that they suggest has promising uses ...
- The Alliance for Regenerative Medicine Releases Q3 2019 Sector Report, Highlighting Industry Trends and Metricson November 5, 2019 at 4:57 pm
WASHINGTON, D.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly sector report, offering an in-depth look ...
- Regenerative medicine technology targets cause of low back painon November 5, 2019 at 6:32 am
Since the intervertebral disc does not have a blood supply, traditional cell-based regenerative medicine techniques such as stem cell injection have encountered roadblocks in the spine. Purmessur ...
- Regenerative Medicine Market 2019 Global Technology, Consumption, Segmentation, Growth, Development, Trends and forecasts to 2026on November 5, 2019 at 6:00 am
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them ...
- AIVITA Biomedical to Present at Upcoming Regenerative Medicine, Oncology and Investor Conferences in Novemberon November 1, 2019 at 7:20 pm
IRVINE, Calif., Nov. 1, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that it will be presenting at the following ...
via Bing News